What is Sphingolipidosis with epilepsy?
Sphingolipidosis with epilepsy does not yet have FDA-approved treatments tracked on UniteRare.
Key symptoms:
Seizures or epilepsyDevelopmental delayLoss of previously learned skills (regression)Muscle stiffness or spasticityMuscle weaknessDifficulty walking or problems with coordinationVision loss or visual problemsIntellectual disabilityInvoluntary jerking movements (myoclonus)Difficulty swallowingSpeech difficultiesBehavioral changesEnlarged liver or spleen in some forms
- Inheritance
- Autosomal recessive
- Passed on when both parents carry the same gene change; often skips generations
- Age of Onset
- Variable
- Can begin at different ages, from infancy through adulthood
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for Sphingolipidosis with epilepsy.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for Sphingolipidosis with epilepsy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for Sphingolipidosis with epilepsy.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Sphingolipidosis with epilepsy.
Community
No community posts yet. Be the first to share your experience with Sphingolipidosis with epilepsy.
Start the conversation →Latest news about Sphingolipidosis with epilepsy
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for Sphingolipidosis with epilepsy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific type of sphingolipidosis does my child or family member have, and which gene is affected?,What seizure medications are recommended, and what side effects should I watch for?,Are there any disease-modifying treatments or clinical trials available for this specific condition?,How often should we have follow-up appointments and what monitoring tests are needed?,What therapies (physical, occupational, speech) would be most helpful right now?,Should other family members be tested, and what are the chances of having another affected child?,What emergency plan should we have in place for prolonged seizures?
Common questions about Sphingolipidosis with epilepsy
What is Sphingolipidosis with epilepsy?
Sphingolipidosis with epilepsy is a rare group of inherited metabolic disorders in which the body cannot properly break down certain fatty substances called sphingolipids. Sphingolipids are important building blocks of cell membranes, especially in the brain and nervous system. When these fats build up because of missing or faulty enzymes, they damage nerve cells and other tissues. This leads to a range of neurological problems, with seizures (epilepsy) being a prominent and defining feature of this particular subgroup. Patients with sphingolipidosis with epilepsy typically experience recurre
How is Sphingolipidosis with epilepsy inherited?
Sphingolipidosis with epilepsy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Frequently asked questions about Sphingolipidosis with epilepsy
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is Sphingolipidosis with epilepsy?
Sphingolipidosis with epilepsy is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:371442). It is typically inherited as autosomal recessive. Age of onset is generally variable. For verified primary sources, see the UniteRare Sphingolipidosis with epilepsy page.
How is Sphingolipidosis with epilepsy inherited?
Sphingolipidosis with epilepsy follows autosomal recessive inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for Sphingolipidosis with epilepsy?
Approved treatments for Sphingolipidosis with epilepsy are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for Sphingolipidosis with epilepsy?
Active clinical trials for Sphingolipidosis with epilepsy are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for Sphingolipidosis with epilepsy?
Verified Sphingolipidosis with epilepsy specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full Sphingolipidosis with epilepsy page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.